Coenzyme Q10 and Dementia: A Systematic Review

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

It is well known that coenzyme Q 10 (CoQ 10 ) has important antioxidant properties. Because one of the main mechanisms involved in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative diseases is oxidative stress, analysis of the concentrations of CoQ 10 in different tissues of AD patients and with other dementia syndromes and the possible therapeutic role of CoQ 10 in AD have been addressed in several studies. We performed a systematic review and a meta-analysis of these studies measuring tissue CoQ 10 levels in patients with dementia and controls which showed that, compared with controls, AD patients had similar serum/plasma CoQ 10 levels. We also revised the possible therapeutic effects of CoQ 10 in experimental models of AD and other dementias (which showed important neuroprotective effects of coenzyme Q 10 ) and in humans with AD, other dementias, and mild cognitive impairment (with inconclusive results). The potential role of CoQ 10 treatment in AD and in improving memory in aged rodents shown in experimental models deserves future studies in patients with AD, other causes of dementia, and mild cognitive impairment.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.